Lobe Sciences Ltd Invites You to Join Us at the Q1 Virtual Investor Summit
Lobe Sciences Ltd Invites You to Join Us at the Q1 Virtual Investor Summit
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2022) - Lobe Sciences Ltd (CSE: LOBE) (OTCQB: LOBEF) today announced that Philip Young CEO will be attending the Q1 Virtual Investor Summit. During this presentation Lobe's CEO Philip Young will provide highlights of the Company's plans for for advancing into human clinical trials in 2022. The presentation will be webcast and an archived recording will be made available in the investors' section of the Lobe Sciences website.
温哥華，不列顛哥倫比亞省-(Newsfile Corp.-2022年2月22日)洛普科學有限公司納斯達克股票代碼：LOPE)(場外交易代碼：LOBEF)今天宣佈，Philip Young首席執行官將出席第一季度虛擬投資者峯會。在本次演講中，環球網首席執行官菲利普·楊將重點介紹該公司2022年進入人體臨牀試驗的計劃。報告將進行網絡直播，並將在波瓣科學網站的投資者部分提供存檔錄音。
| Event: | Q1 Investor Summit |
| Date: | March 8-9th, 2022 |
| Presentation: | March 9th at 10:15 AM ET |
| Location: |
| 活動： | 第一季度投資者峯會 |
| 日期： | 2022年3月8日至9日 |
| 演示文稿： | 3月9日美國東部時間上午10：15 |
| 位置： |
- 1x1s will be available for qualified investors.
- The conference is completely complimentary to qualified investors. Please register at Complimentary Investor Registration.
- 合格投資者將可獲得1x1。
- 這次會議完全是對合格投資者的免費贈送。請於免費投資者登記處登記。
About Lobe Sciences Ltd
關於洛普科學有限公司
Lobe Sciences is a life sciences company focused on developing sub-psychedelic doses of psychedelic medicines targeting the 5-HT2A receptor. The Company, through collaborations with industry-leading partners, is engaged in drug research and development using psychedelic compounds in conjunction with NAC (N-acetyl cysteine) to improve brain and mental health and wellness.
洛普科學公司是一家生命科學公司，專注於開發針對5-HT2A受體的亞迷幻劑量的迷幻藥物。該公司通過與業界領先的合作伙伴合作，致力於使用迷幻化合物和NAC(N-乙酰半胱氨酸)進行藥物研究和開發，以改善大腦和精神健康。
For further information:
有關更多信息，請訪問：
Lobe Sciences Ltd
Philip Young
949-505-2653
info@lobesciences.com
洛普科學有限公司
菲利普·楊
949-505-2653
郵箱：info@lobesciences.com
About the Investor Summit
關於投資者峯會
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. Contact: info@investorsummitgroup.com.
投資者峯會(前身為MicroCap Conference)是一個獨家、獨立的會議，致力於將小盤股和微盤股公司與合格投資者聯繫起來。第一季度投資者峯會將虛擬舉行，有90多家公司和500多名投資者參加，其中包括機構投資者、家族理財室和高淨值投資者。參與行業：生物技術、通信服務、消費、能源、能源/技術、金融、醫療保健、工業、材料、房地產、技術和技術/加密。聯繫人：info@investorsummitgroup.com
譯文內容由第三人軟體翻譯。